Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen

Arthritis Research and Therapy

Volumn 9, Issue 5, 2007, Pages

  Inglis, Julia J ^a   Criado, Gabriel ^a   Medghalchi, Mino ^a   Andrews, Melanie ^a   Sandison, Ann ^b   Feldmann, Marc ^a   Williams, Richard O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIRHEUMATIC AGENT; COLLAGEN TYPE 2; DEXAMETHASONE; INDOMETACIN; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; IMMUNIZATION; INCIDENCE; MALE; MOUSE; NONHUMAN; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; ANIMAL; ARTHRITIS; C57BL MOUSE; CATTLE; CHEMICALLY INDUCED DISORDER; CHICKEN; COMPARATIVE STUDY; DBA MOUSE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY; SPECIES DIFFERENCE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CATTLE; CHICKENS; COLLAGEN TYPE II; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 36949009473     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2319     Document Type: Article

References (21)

1. Rosloniec EF Brand DD Myers LK Whittington KB Gumanovskaya M Zaller DM Woods A Altmann DM Stuart JM Kang AH An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen J Exp Med 1997, 185:1113-1122. 10.1084/jem.185.6.1113 9091584
2. Rosloniec EF Brand DD Myers LK Esaki Y Whittington KB Zaller DM Woods A Stuart JM Kang AH Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen J Immunol 1998, 160:2573-2578. 9510154
3. Fugger L Rothbard JB Sonderstrup-McDevitt G Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen Eur J Immunol 1996, 26:928-933. 10.1002/eji.1830260431 8625990
4. Feldmann M Steinman L Design of effective immunotherapy for human autoimmunity Nature 2005, 435:612-619. 10.1038/nature03727 15931214
5. Holmdahl R Bockermann R Backlund J Yamada H The molecular pathogenesis of collagen-induced arthritis in mice - a model for rheumatoid arthritis Ageing Res Rev 2002, 1:135-147. 10.1016/S0047-6374(01)00371-2 12039453
6. Williams RO Feldmann M Maini RN Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci USA 1992, 89:9784-9788. 50217 1409699 10.1073/pnas.89.20.9784
7. Feldmann M Maini RN Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases Nat Med 2003, 9:1245-1250. 10.1038/nm939 14520364
8. Pan M Kang I Craft J Yin Z Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response J Clin Immunol 2004, 24:481-491. 10.1023/ B:JOCI.0000040919.16739.44 15359107
9. Chu CQ Song Z Mayton L Wu B Wooley PH IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints Ann Rheum Dis 2003, 62:983-990. 1754310 12972478 10.1136/ard.62.10.983
10. Campbell IK Rich MJ Bischof RJ Dunn AR Grail D Hamilton JA Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice J Immunol 1998, 161:3639-3644. 9759887
11. Campbell IK Hamilton JA Wicks IP Collagen-induced arthritis in C57BL/6 (H-2b) mice: New insights into an important disease model of rheumatoid arthritis European Journal Of Immunology 2000, 30:1568-1575. 10.1002/ 1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R 10898492
12. Kai H Shibuya K Wang Y Kameta H Kameyama T Tahara-Hanaoka S Miyamoto A Honda S Matsumoto I Koyama A Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice Immunology 2006, 118:233-239. 1782291 16771858 10.1111/j.1365-2567.2006.02361.x
13. Williams RO Collagen-induced arthritis as a model for rheumatoid arthritis Methods Mol Med 2004, 98:207-216. 15064442
14. Vingsbo C Larsson P Andersson M Holmdahl R Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats Scand J Immunol 1993, 37:337-342. 10.1111/j.1365-3083.1993.tb02562.x 8441920
15. Senturk N Keles GC Kaymaz FF Yildiz L Acikgoz G Turanli AY The role of ascorbic acid on collagen structure and levels of serum interleukin-6 and tumour necrosis factor-alpha in experimental lathyrism Clin Exp Dermatol 2004, 29:168-175. 10.1111/j.1365-2230.2004.01473.x 14987276
16. Feldmann M Maini RN Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 2001, 19:163-96. 163-196. 10.1146/ annurev.immunol.19.1.163 11244034
17. Cutolo M Sulli A Pizzorni C Seriolo B Straub RH Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis Ann Rheum Dis 2001, 60:729-735. 1753808 11454634 10.1136/ard.60.8.729
18. Ozegbe P Foey AD Ahmed S Williams RO Impact of cAMP on the T-cell response to type II collagen Immunology 2004, 111:35-40. 1782387 14678197 10.1111/j.1365-2567.2004.01768.x
19. Delano DL Montesinos MC Desai A Wilder T Fernandez P D'Eustachio P Wiltshire T Cronstein BN Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation Arthritis Rheum 2005, 52:2567-2575. 1343510 16059892 10.1002/art.21208
20. Lipsky PE van der Heijde DM St Clair EW Furst DE Breedveld FC Kalden JR Smolen JS Weisman M Emery P Feldmann M Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group The New England Journal Of Medicine 2000, 343:1594-1602. 10.1056/ NEJM200011303432202 11096166
21. Ory PA Interpreting radiographic data in rheumatoid arthritis Ann Rheum Dis 2003, 62:597-604. 1754596 12810418 10.1136/ard.62.7.597